A

ACADIA Pharmaceuticals

D
ACAD
USD
1.42
(8.993%)
Market Closed
110,935.00
Volume
0.387
EPS
-
Div Yield
90.579
P/E
2,854,726,854.92
Market Cap
Today
8.9930%
1 Week
18.119%
1 Month
16.876%
6 Months
-0.463%
12 Months
-26.766%
Year To Date
-45.034%
All Time
0%

Title:
ACADIA Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Do you need help or have a question?